EXPLORING PATHOLOGICAL OBSTACLES

BY AUTHOR / MONTH DAY 2021 / 2 min read

An expert panel discusses the diagnostic challenges of mixed pathology in patients with Alzheimer’s disease through a patient case study at the International Conference on Alzheimer’s and Parkinson’s Disease (AD/PD) 2019.

Explore more videos

THE SYDNEY MEMORY AND AGEING STUDY

THE SYDNEY MEMORY AND AGEING STUDY

Prof Henry Brodaty discusses mild cognitive impairment and key findings from one of  Australia’s largest and longest running studies of ageing and cognitive health. 

Login Required

DELINEATING THE CAUSE OF MEMORY IMPAIRMENT

DELINEATING THE CAUSE OF MEMORY IMPAIRMENT

An expert panel discusses a patient case study which highlights the Alzheimer’s continuum as well as the challenges of detecting early cognitive change at the 6th Congress of the European Academy of Neurology (EAN) 2020.

Login Required

WHAT DOES AN EARLY DIAGNOSIS MEAN FOR PATIENTS?

WHAT DOES AN EARLY DIAGNOSIS MEAN FOR PATIENTS?

Delays in diagnosis of Alzheimer’s disease can mean lost opportunities for medical and social intervention. Prof Henry Brodaty discusses the importance of a timely diagnosis, what barriers remain and what the future holds for people living with dementia.

Login Required

THE MULTIDISCIPLINARY MEMORY CLINIC

THE MULTIDISCIPLINARY MEMORY CLINIC

A/Prof Rebekah Ahmed shares her insights into how an integrated multidisciplinary approach can enhance and streamline Alzheimer’s disease diagnosis and management in memory clinics.

Login Required

HOW DO WE BETTER DETECT AND REFER PATIENTS EARLIER?

HOW DO WE BETTER DETECT AND REFER PATIENTS EARLIER?

Dr Kathleen Welsh-Bohmer discusses future innovations and the use of digital detection tools and telemedicine to improve early diagnosis at the Alzheimer’s Association International Conference (AAIC) 2020.

Login Required

LEVERAGING BIOMARKERS FOR AN EARLIER DIAGNOSIS

LEVERAGING BIOMARKERS FOR AN EARLIER DIAGNOSIS

From neuroimaging to CSF and blood-based biomarkers, Prof Chris Rowe discusses the future use of biomarkers for aiding the early diagnosis of Alzheimer’s disease at the Alzheimer’s Association International Conference (AAIC) 2020.

Login Required

THE BRAIN BANK OF THE FUTURE

THE BRAIN BANK OF THE FUTURE

A/Prof Greg Sutherland, Deputy Director of the NSW Tissue Resource Centre, explains how advances in molecular technology have changed brain banking, and provide potential to better understand the neuropathology underlying Alzheimer’s disease.

Login Required

THE CLINICAL IMPACT OF BIOMARKERS

THE CLINICAL IMPACT OF BIOMARKERS

Prof Henry Brodaty, Scientia Professor at UNSW, and A/Prof Rebekah Ahmed, Director of the Memory and Cognition Clinic at Royal Prince Alfred Hospital, discuss recent advances in the identification of Alzheimer’s disease biomarkers, and what this may mean for future diagnosis.

Login Required

BRAIN BANKS AND ALZHEIMER'S DISEASE

BRAIN BANKS AND ALZHEIMER'S DISEASE

A/Prof Greg Sutherland, Deputy Director of the NSW Tissue Resource Centre, explains how brain banks can further our understanding of the early changes associated with Alzheimer’s disease and why brain banks will be important to future research.

Login Required

The views and opinions expressed in these videos are the views and opinions of the speakers and do not necessarily reflect those of Biogen.